Iván Olmos Cansino

Iván Olmos Cansino is the head of Birmex, the Mexican biological and reagent laboratory, who has recently been in the news for addressing irregularities in the consolidated purchase of medications for 2025-2026. His leadership comes at a challenging time, as the Mexican government seeks to rectify issues that have led to significant shortages of essential medicines, which have drawn scrutiny and criticism from various sectors.